nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenacemide—SCN1A—hindbrain—amyotrophic lateral sclerosis	0.291	0.291	CbGeAlD
Phenacemide—SCN1A—brainstem—amyotrophic lateral sclerosis	0.167	0.167	CbGeAlD
Phenacemide—SCN1A—medulla oblongata—amyotrophic lateral sclerosis	0.116	0.116	CbGeAlD
Phenacemide—SCN1A—spinal cord—amyotrophic lateral sclerosis	0.104	0.104	CbGeAlD
Phenacemide—SCN1A—nervous system—amyotrophic lateral sclerosis	0.0875	0.0875	CbGeAlD
Phenacemide—SCN1A—central nervous system—amyotrophic lateral sclerosis	0.0843	0.0843	CbGeAlD
Phenacemide—SCN1A—cerebellum—amyotrophic lateral sclerosis	0.0823	0.0823	CbGeAlD
Phenacemide—SCN1A—brain—amyotrophic lateral sclerosis	0.0669	0.0669	CbGeAlD
